Ultrasensitive CRP, also known as ultrasensitive C-reactive protein, is elevated with no direct link to symptoms, and is mainly used for clinical auxiliary diagnosis of cardiovascular disease and neonatal infectious diseases.
1. Cardiovascular disease, according to the hs-CRP level, patients can be categorized according to the risk of cardiovascular disease: i.e., <1mg/L is a relatively low risk, 1.0~3.0mg/L is a moderate risk, >3.0mg/L is a high risk, and it is recommended to give anti-inflammatory and anti-embolism treatments at the same time, and >10mg/L indicates that there may be other infections (bacterial or viral infections).
2. Neonatal infectious diseases, due to the incomplete development of the liver and immune system of newborns, so the basal level of CRP in newborns is usually very low (<1~2mg/L), while bacterial infections in newborns tend to develop very quickly, there is not enough time to produce a large amount of CRP, so the CRP value for judging bacterial infections is different from that of adults, >2mg/L that is of reference significance.
If you use the conventional CRP5~8mg/L lowest reported sensitivity can not reflect the small changes in the existing bacterial infection. Only hsCRP can meet the needs of neonatal bacterial infection diagnosis.
Ultra-sensitive CRP can only be used as one of the indicators of cardiovascular disease risk, if there are people with elevated ultra-sensitive CRP, it is recommended to go to the hospital for relevant examinations to clarify the cause of the disease, and the doctor will give the diagnosis and treatment after comprehensive evaluation.